Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -11.90 | 17.75 |
| PEG Ratio (TTM) | 0.04 | 2.31 |
| P/S Ratio (TTM) | 2.76 | 3.96 |
| P/B Ratio (TTM) | 9.76 | 2.15 |
| P/FCF Ratio (TTM) | 23.93 | -1.81 |
| Price to 5YR AVG Earnings Ratio | 14.57 | 9.11 |
| Price to 5YR AVG FCF Ratio | 4.14 | -193.92 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -4.75% | 1.13% |
| ROE (TTM) | -54.65% | 11.77% |
| Net Profit Margin (TTM) | -23.21% | 20.55% |
| ROIC 5YR AVG | 16.54% | 14.81% |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -195.58% | 154.06% | 80.85% |
| Revenue | -10.83% | 12.08% | 3.90% |
| Net Income | -198.10% | 120.20% | 60.67% |
| Cash Flow | 242.95% | 354.99% | 208.32% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.89 | 3.36 |
| Quick Ratio (TTM) | 1.89 | 3.28 |
| D/E Ratio (TTM) | 13.26 | 2.71 |
| Interest Coverage (TTM) | -1.30 | 1.72 |
| Piotroski F-Score | 6 | 4 |
| Altman Z-Score | 1.10 | 1.18 |
| LTL to 5YR AVG FCF | N/A | -292.74 |
| Shares Outstanding Growth 5YR AVG | -4.87% | 1.49% |